Phase I/II Studies of Azacitidine Alone or with Pracinostat for Patients with AML
Garcia-Manero G et al. Final results from a Phase 2 study of pracinostat in combination with azacitidine in elderly patients with acute myeloid leukemia (AML). Proc ASH 2015;Abstract 453.
Savona MR et al. CC-486 (oral azacitidine) monotherapy in patients with acute myeloid leukemia (AML). Proc ASH 2015;Abstract 452.
Dr Stone is Director of the Adult Leukemia Program at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School in Boston, Massachusetts.
|